🏛️ Verified NIH Record • Updated 2026-05-13
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) (NCT06696443)
A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Vertex Pharmaceuticals Incorporated
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.
Who can join: Review the eligibility criteria below.
Location: Pinnacle Research Group, LLC — Anniston, Alabama
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (65 Sites)
Showing the first 25 of 65 sites.
- Pinnacle Research Group, LLC — Anniston, Alabama
- AMR Daphne, AL — Daphne, Alabama
- Scottsdale Clinical Trials — Scottsdale, Arizona
- Neuro-Pain Medical Center — Fresno, California
- Long Beach Research Institute — Long Beach, California
- Angel City Research, Inc — Los Angeles, California
- Empire Clinical Research — Pomona, California
- Clinical Trials Research — Sacramento, California
- Velocity Clinical Research, San Bernardino — San Bernardino, California
- SCLA Management - Pain Management and Injury Relief — Thousand Oaks, California
- Velocity Clinical Research - Denver — Englewood, Colorado
- Velocity Clinical Research - Washington DC — Washington D.C., District of Columbia
- AMR-Miami — Coral Gables, Florida
- Accel Research - Deland — DeLand, Florida
- Suncoast Research Associates - Miami — Doral, Florida
- AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida
- Velocity Clinical Research - Hallandale Beach — Hallandale, Florida
- CNS Healthcare - Jacksonville — Jacksonville, Florida
- Accel Research Site - St. Petersburg/Largo — Largo, Florida
- Accel Research Sites - Maitland — Maitland, Florida
- 3Sync Research - Miami Lakes — Miami Lakes, Florida
- Suncoast Clinical Research - New Port Richey — New Port Richey, Florida
- Conquest Clinical Research - Orlando - Neuro — Orlando, Florida
- Conquest Clinical Research - Winter Park — Winter Park, Florida
- Accel Research - Decatur — Decatur, Georgia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Peripheral Neuropathic Pain
- Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy — Cullman, Alabama
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy — Anniston, Alabama
- MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP — Fredericksburg, Texas
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy — Birmingham, Alabama
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain — Birmingham, Alabama
Explore by condition: All Diabetic Peripheral Neuropathic Pain clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.